BFSG LLC’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-90
Closed -$11.5K 682
2025
Q1
$11.5K Hold
90
﹤0.01% 486
2024
Q4
$11.9K Hold
90
﹤0.01% 487
2024
Q3
$13.1K Hold
90
﹤0.01% 475
2024
Q2
$12.4K Hold
90
﹤0.01% 457
2024
Q1
$12.3K Hold
90
﹤0.01% 477
2023
Q4
$12.2K Buy
+90
New +$11K ﹤0.01% 444
2022
Q1
Sell
-35,048
Closed -$5.35M 215
2021
Q4
$5.35M Sell
35,048
-621
-2% -$96.1K 0.74% 45
2021
Q3
$5.77M Buy
35,669
+129
+0.4% +$21.7K 0.88% 37
2021
Q2
$5.82M Buy
+35,540
New +$5.47M 1.04% 30
2017
Q2
Sell
-2,310
Closed -$226K 126
2017
Q1
$226K Buy
+2,310
New +$221K 0.11% 94

Other funds holding IBB

BFSG LLC's IBB Position: Q2 2025 in Review

BFSG LLC sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 90 shares — an estimated $11.5K sold.

BFSG LLC first reported a position in IBB in Q1 2017 and held it in 10 quarters. The position peaked at $5.82M in Q2 2021. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

  • BFSG LLC reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
  • BFSG LLC sold 90 iShares Biotechnology ETF shares in Q2 2025, an estimated $11.5K.
  • BFSG LLC first reported a position in iShares Biotechnology ETF in Q1 2017 and held it in 10 quarters.
  • BFSG LLC's iShares Biotechnology ETF position peaked at $5.82M in Q2 2021.
  • 797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on BFSG LLC's 13F filing for Q2 2025, filed 15 Jul 2025.